Navigation Links
WeissComm Partners Names Tom Jones Managing Director to Deepen Global Product Communications Offering

NEW YORK and SAN FRANCISCO, Feb. 19 /PRNewswire/ -- WeissComm Partners, the largest independent communications agency focused on the healthcare industry, today announced the appointment of Tom Jones as managing director. Jones joins WeissComm from Novartis Pharmaceuticals Corporation where he was executive director of communications, overseeing the creation, development and implementation of public relations programs for the company's growth driver brands. Prior to that, he was vice president and group manager at Ketchum where he contributed greatly to the growth of the healthcare practice.

For more than 15 years, Jones has developed and executed award-winning public relations and corporate communications initiatives, built and managed high-performance teams, and provided measurable business results for leading pharmaceutical and biotechnology companies, including AstraZeneca, Aventis, Genentech, Merck, Novartis and Pfizer.

"PR has never been more important to the healthcare industry," said Diane Weiser, COO of WeissComm Partners. "Tom is a trusted colleague with a proven track record who can hit the ground running to provide clients with the no-nonsense, on-target, strategic counsel and execution they have come to expect from our team."

Jones has directed consumer and professional communications programs on behalf of some of the world's largest prescription medicines across a broad range of therapeutic areas, including neurology, cardiology, diabetes, respiratory, dermatology, arthritis and gastrointestinal disorders. As part of these initiatives, he has developed and managed corporate and brand communications, consumer and professional outreach, issues management, media and advocacy relations, corporate reputation management, leadership communications, internal communications and new media initiatives.

"I joined WeissComm to be part of a truly senior-based team of healthcare professionals and apply my agency and corporate in-house experience to a diverse group of healthcare clients," said Jones. "I am looking forward to working with respected and trusted peers and colleagues to expand WeissComm's global product communications offering and continue to raise the bar on its client-agency partnerships."

About WeissComm Partners

WeissComm Partners is a full-service public relations agency focused exclusively on serving the corporate and product communications needs of leading biotechnology, pharmaceutical, device and diagnostic companies. At WeissComm, senior counselors are the client's everyday team. WeissComm's team of seasoned professionals specialize in healthcare marketing, corporate and product PR, investor and advocacy relations, clinical trial recruitment and grassroots direct-to-patient PR programs. Ranked among the top independent PR firms in the United States, WeissComm serves clients globally with offices in San Francisco, New York and Chicago, and in London via a strategic alliance with Resolute Communications. For more information, please visit

SOURCE WeissComm Partners
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
2. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. MDS to Present at Thomas Weisel Partners Healthcare Conference
8. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
9. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... the 1980s we have seen vast improvements in scientific research and discoveries, leading ... strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric ... the focus of numerous abstracts accepted for presentation here, at the 101st Annual ... abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools for ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... , ... XTC Semifinals 2016 - CES, Las Vegas, Nevada - ... CES 2016, the world’s largest Consumer Electronic Show, where they will present to a ... of Pacific Investments Veronica Serra, and venture capitalist Tim Draper among many other top ...
(Date:12/1/2015)... ... 2015 , ... SonaCare Medical congratulates the University College London ... on November 18th. This prestigious award recognizes annually organizations that cultivate truly innovative ... medical landscape. , The UCLH team won the award for their innovative approach ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , December 1, 2015 ... new market research report "Nucleic Acid Labeling Market by ... Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription, ... published by MarketsandMarkets, The global market is expected to ... Million in 2015, growing at a CAGR of 8.65%. ...
(Date:12/1/2015)... , December 1, 2015 Russia ... clinical trials. 70% of new drugs registered in Europe ... Russia . --> Russia has always been ... of new drugs registered in Europe in 2015 ... --> Russia has always been a country ...
(Date:12/1/2015)... 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... announced today that the company will present at the LD ... at the Luxe Sunset Boulevard Hotel in Los ... Relmada Therapeutics, will present on Thursday, December 3, at 9:00 ... . Please register at least 10 minutes prior to the ...
Breaking Medicine Technology: